Integer Holdings Corporation
Rank #413ValueITGR · NYSE · Healthcare
Integer Holdings Corporation (ITGR) — Rank #413 by gross profitability (GP/assets 0.15) · ROE 6.0% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0001114483 · all metrics point-in-time as of the filing date.
About
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
Show moreShow less
The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; orthopedics, minimally invasive surgery, and general surgery devices; and portable medical devices, including patient monitoring, ventilators, portable defibrillators, portable ultrasound, and X-Ray machines. Furthermore, the company provides medical technologies; supplies medical stamped components, and shallow and deep draw casings and assemblies; and epicardial pacing leads. It serves multi-national original equipment manufacturers and affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, cardio and vascular, and advanced surgical and portable medical markets. The company provides its products under the Greatbatch Medical and the Lake Region Medical brands. The company was formerly known as Greatbatch, Inc. and changed its name to Integer Holdings Corporation in July 2016.
Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.
- Industry
- Medical Devices
- Sector
- Healthcare
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- integer.net
Financials
Stable
Direction over 5 fiscal years
- Free cash flowimproving
- Gross marginstable
- Gross profitabilityimproving
- Net cashdeteriorating
- Operating marginimproving
- Return on equitystable
- Share count (dilution)deteriorating
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-23 | 2024-12-31filed 2025-02-20 | 2023-12-31filed 2024-02-20 | 2022-12-31filed 2023-02-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 1,853.6 | 1,716.6 | 1,596.7 | 1,376.1 |
| Revenue growth (YoY) | 8.0% | 10.3% | 16.0% | 12.7% |
| Gross profit | 500.4 | 459.0 | 418.3 | 359.0 |
| Gross margin | 27.0% | 26.7% | 26.2% | 26.1% |
| Net income | 102.8 | 119.9 | 90.7 | 66.4 |
| Net margin | 5.5% | 7.0% | 5.7% | 4.8% |
| EPS (diluted) | $2.89 | $3.36 | $2.69 | $1.99 |
| EPS growth (YoY) | -14.0% | 24.9% | 35.2% | — |
| Cash flow | ||||
| Operating cash flow | 196.1 | 205.2 | 180.2 | 116.4 |
| Capital expenditures | 91.0 | 105.4 | 119.9 | 74.7 |
| Free cash flow | 105.1 | 99.8 | 60.3 | 41.7 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?